 | Up a level |
Bruix, Jordi; Tak, Won-Young; Gasbarrini, Antonio; Santoro, Armando; Colombo, Massimo; Lim, Ho-Yeong; Mazzaferro, Vincenzo; Wiest, Reiner; Reig, María; Wagner, Andrea; Bolondi, Luigi (2013). Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: Multicentre, open-label, phase II safety study. European journal of cancer, 49(16), pp. 3412-3419. Elsevier 10.1016/j.ejca.2013.05.028
Bolondi, Luigi; Burroughs, Andrew; Dufour, Jean-François; Galle, Peter R; Mazzaferro, Vincenzo; Piscaglia, Fabio; Raoul, Jean Luc; Sangro, Bruno (2012). Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions. Seminars in liver disease, 32(4), pp. 348-59. New York, N.Y.: Thieme Medical Publishers 10.1055/s-0032-1329906
